Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Kaye Edward M. MD Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 448 shares @ $27.88, valued at $12.5k
07/05/2023 4 Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 374 shares @ $33.36, valued at $12.5k
05/18/2023 4 Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 5,000 shares @ $0
Granted 10,000 options to buy @ $37.89, valued at $378.9k
04/05/2023 4 Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 298 shares @ $37.71, valued at $11.2k
03/17/2023 4 Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Granted 213,000 options to buy @ $9.15, valued at $1.9M
Granted 142,000 restricted stock units @ $0
01/04/2023 4 Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 253 shares @ $44.35, valued at $11.2k
12/09/2022 4 Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Granted 167,050 options to buy @ $7.07, valued at $1.2M
10/05/2022 4 Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 220 shares @ $51.11, valued at $11.2k
08/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/01/2022 4 Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 293 shares @ $38.38, valued at $11.2k
03/17/2022 4 Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Granted 308,000 options to buy @ $20.34, valued at $6.3M
01/04/2022 4 Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 244 shares @ $46, valued at $11.2k
12/23/2021 4 Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Sold 15,000 shares @ $45, valued at $675k
Exercised 15,000 options to buy @ $7.61, valued at $114.2k
10/04/2021 4 Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 306 shares @ $36.74, valued at $11.2k
07/08/2021 4 Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 63 shares @ $19.77, valued at $1.2k
07/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2021 4 Kaye Edward M. MD (Director) has filed a Form 4 on Avidity Biosciences, Inc.
Txns: Granted 15,000 options to buy @ $26.09, valued at $391.4k
05/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/04/2021 4 Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Granted 200,800 options to buy @ $60, valued at $12M
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2021 4 Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Exercised 10,000 options to buy @ $0.6, valued at $6k
12/18/2020 4 Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Sold 19,806 shares @ $60, valued at $1.2M
Sold 5,194 shares @ $60, valued at $311.6k
11/30/2020 4 Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Sold 12,152 shares @ $50, valued at $607.6k
11/25/2020 4 Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Sold 12,848 shares @ $50, valued at $642.4k
10/05/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/15/2020 4 Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Exercised 50,000 options to buy @ $0.6, valued at $30k
03/26/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy